Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains.

The Journal of antimicrobial chemotherapy - 1 Aug 2004

Eick Sigrun, Schmitt Andrea, Sachse Svea, Schmidt Karl-Hermann, Pfister Wolfgang

Abstract excerpt

OBJECTIVES: The objective of the study was to evaluate the in vitro activity of ciprofloxacin, gatifloxacin and moxifloxacin against 16 Porphyromonas gingivalis strains. METHODS: MICs of the quinolones were established by Etest and the agar dilution technique. Experiments focused on determination of the spontaneous mutation rate and the induction of resistant strains, using 0.25-fold MIC of antibiotic. Fragments...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aza Compounds
Share to Bacteroidaceae Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Gyrase

Share to DNA Topoisomerase IV

Share to Moxifloxacin

Share to Periodontitis

Share to Porphyromonas gingivalis

Share to Quinolines

Source

Identifiers

PMID: 15231772
DOI: 10.1093/jac/dkh354

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains.PMID 15231772Read ↗

Comparative in-vitro activity of new quinolones against clinical isolates and resistant mutants.Semantic proximity Read ↗

gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.Semantic proximity Read ↗

Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus.Semantic proximity Read ↗

Quinolones: a class of antimicrobial agentsSemantic proximity Read ↗

Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.Semantic proximity Read ↗

Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.Semantic proximity Read ↗

[Study investigating the activity of several fluoroquinolones against Pseudomonas aeruginosa using the mutant prevention concentration].Semantic proximity Read ↗

Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin.Semantic proximity Read ↗

[Mutant prevention concentrations of fluoroquinolones for Staphylococcus aureus].Semantic proximity Read ↗

In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.Semantic proximity Read ↗

Designing fluoroquinolone breakpoints for Streptococcus pneumoniae by using genetics instead of pharmacokinetics-pharmacodynamics.Semantic proximity Read ↗

Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.